call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Global Pharmacogenomics Market
Inquire Before Buying Request for Sample

Global Pharmacogenomics Market

Home Healthcare And Pharmaceutical Global Pharmacogenomics Market

Pharmacogenomics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented By Technology (DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry); By Application (Drug Discovery, Neurology, Oncology, Pain Management, Others); By End User (Hospitals, Research organizations, Others); By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: January 2023
  • Report ID: BWC22589
  • Available Format: PDF
  • Page: 240

Report Overview

An increasing focus on the development of therapies to treat the growing prevalence of chronic diseases, a spurring demand for precision medicine, use of Sanger technology and next-generation sequencing in academic and institutional research projects, governments’ supportive measures for healthcare could boost the growth of Global Pharmacogenomics Market during the forecast period between 2022 and 2028.

Global Pharmacogenomics Market - Industry Trends & Forecast Report, 2028

Global pharmacogenomics market size is projected to grow at a CAGR of 12.4% during the forecast period between 2022 and 2028. The major factor driving the growth of global pharmacogenomics market is the increase in demand for precision medicine. In contrast to the one-drug-fits-all approach to healthcare, precision medicine advocates healthcare customization, with medical decisions, treatments, procedures, or products tailored to a specific group of patients. Precision medicine is in high demand because it is the most cutting-edge in oncology and has exciting new applications outside of oncology and late-stage illnesses like rare and genetic diseases. Integrating genetic and environmental data about specific diseases and their responses to specific treatments is the main goal of precision medicine. A key trend that is becoming increasingly popular in the pharmacogenomics market is technological development. Pharmaceutical companies are focusing on different pharmacogenomics analysis techniques to offer affordable solutions for screening known polymorphisms and finding novel variants.

Global Pharmacogenomics Market - Overview

Pharmacogenomics (also known as pharmacogenetics) is a branch of genomic medicine that uses a patient's genomic information to tailor drug selection in their medical treatment. Pharmacogenomics aims to provide a more individualized (or precise) approach to the use of available medication in treating patients in this way. Polymerase chain reaction (PCR), microarray, deoxyribonucleic acid (DNA) sequencing, mass spectrometry, and electrophoresis are all used in pharmacogenomics. The genetic tests used in pharmacogenomics aid in determining disease susceptibility and the efficacy of newly developed drugs.

Growth Drivers

Increasing number of health disorders

The development of efficient drugs may be influenced by the rising incidence of gastrointestinal-related disorders, inflammatory bowel diseases, and family histories of illnesses like cancer. The demand for effective, efficient, and innovative medical treatment of anorectal disorders would consequently increase significantly.

Increasing infrastructure spending for healthcare

The rising cost of healthcare, which aids in developing the market's infrastructure, is another key factor influencing the market's growth rate. Growth and expansion of the healthcare sector, particularly in developing countries, would encourage the use and application of innovative medical tools, technology, and medications. The demand for the treatment of anorectal disorders will consequently rise.

Focused efforts on healthcare research and development

The increasing number of strategic collaborations between public and private market players is driving an increase in the number of R&D activities daily. These capabilities in research and development are being applied to novel drugs and medical technologies, which will drive the demand for anorectal disorder treatment. Furthermore, the presence of a strong pipeline for antiviral drugs, an increasing geriatric population base, and an increase in the prevalence of congenital problems such as vacterl syndrome, digestive disorders, and down syndrome are factors that will accelerate market growth. Other factors, such as the availability of low-cost drugs and rising personal disposable income, will boost the market's growth rate.

Restraints

High costs associated with research and development proficiencies

One of the biggest market restraints is the high costs associated with research and development expertise. Lack of knowledge and the necessary infrastructure in underdeveloped and backward economies, negative health effects from drug use, the length of treatment times, and unfavorable conditions brought on by the COVID-19 outbreak will all further impede market growth. The market growth rate will also be challenged by the slow rate of drug and inhibitor approval as well as the rising number of patent expiry cases.

Impact of COVID-19 on Global Pharmacogenomics Market

Three main ways that COVID-19 pandemic affected the economy directly disruptions in supply & demand and distribution networks and having an economic impact on businesses and financial markets. Many nations, including China, India, Saudi Arabia, the United Arab Emirates, and Egypt, faced difficulties moving drugs from one location to another because of widespread lockdowns. Due to the COVID-19 pandemic, players in the global pharmacogenomics market were confronted with significant difficulties on numerous fronts. One of the biggest issues was the insufficient supply of raw materials needed to make drug formulations due to transportation irregularities. Because of an increase in patients with COVID-19 and other life-threatening illnesses, distributors were witnessing erratic demand for their products from retailers.

Global Pharmacogenomics Market

Segmental Coverage

Global Pharmacogenomics Market - By Technology

Global pharmacogenomics market is divided into DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, and Mass Spectrometry segments. In terms of pharmacogenomics technology, polymerase chain reaction has the fastest-growing market segments and holds the highest market share. Use for amplification in a small DNA segment in irreplaceable circumstances. The pharmacogenomics market is being examined to determine which technology will have the highest growth rate and market share during the projection period.

 Global Pharmacogenomics Market

Global Pharmacogenomics Market - By End User

On basis of the end user, global pharmacogenomics market is divided into Hospitals, Research organizations, and other segments. Due to increased demand and growing awareness among medical professionals due to advanced drug development and technologies with good output and increased therapeutic index, hospitals have the highest revenue share, holding the pharmacogenomics market to the top position throughout the forecast period.

Global Pharmacogenomics Market - By Distribution Channel

On basis of distribution channels, global pharmacogenomics market is divided into Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy segments.

Global Pharmacogenomics Market - By Region

Geographically, global pharmacogenomics market covers five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American pharmacogenomics market dominated the world in 2021 and is expected to maintain its dominance in the coming years. The region's increased adoption of pharmacogenomic practices is being driven by government initiatives to integrate targeted medicine approaches into the mainstream healthcare system. Furthermore, the FDA and the Clinical Laboratory Improvement Amendments (CLIA) have been at the forefront of developing effective and appropriate guidelines and policies to propel the adoption of pharmacogenomic tests by end users.

Competitive Landscape

Competition in global pharmacogenomics market is intense. Major companies in the market include Novartis AG, Mylan N.V., Ferndale Pharma Group, Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, AstraZeneca, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Eli Lilly and Company, Boehringer Ingelheim International GmbH, AbbVie Inc, Allergan, Abbott, and Bayer AG. The key strategies used by these market leaders are new product launches, mergers & acquisitions, and alliances. To grow their market share, these companies are also focusing on investing in innovations, collaborations, and expansions.

Recent Developments

  • In May 2022 - Invitae launched Invitae Pharmacogenomics (PGx) Panel which includes the specialized Invitae Pharmacogenomics Mental Health Panel and access to a clinical decision support tool (CDST).

  • In March 2022 - Day-Lewis announced its plans to be the first to launch a private pharmacogenomic testing service in a community pharmacy.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2018–2021

Base Year – 2021

Estimated Year – 2022

Forecast Period – 2022–2028

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Technology, Application, End User, Distribution Channel, Region

Key Players

Novartis AG, Mylan N.V., Ferndale Pharma Group, Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, AstraZeneca, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Eli Lilly and Company, Boehringer Ingelheim International GmbH, AbbVie Inc, Allergan, Abbott, Bayer AG

 

By Technology

  • DNA Sequencing

  • Microarray

  • Polymerase Chain Reaction

  • Electrophoresis

  • Mass Spectrometry

By Application

  • Drug Discovery

  • Neurology

  • Oncology

  • Pain Management

  • Others

By End User

  • Hospitals

  • Research organizations

  • Others

By Distribution Channel

  • Hospital Pharmacy

  • Online Pharmacy

  • Retail Pharmacy

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Pharmacogenomics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Rise in prevalence of chronic disorders
        2. Surging demand for precision medicine
        3. Increasing adoption of Sanger technology and next-generation sequencing in academic and institutional research projects
      2. Restraints
        1. High costs associated with research and development proficiencies
      3. Opportunities
        1. Rising government investments for healthcare infrastructure
        2. Increasing strategic collaborations among market players
      4. Challenges
        1. Dearth of awareness and required infrastructural facilities
        2. Stringent government regulations
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Pharmacogenomics Market Overview
    1. Market Size & Forecast, 2018–2028
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Technology
        1. DNA Sequencing
        2. Microarray
        3. Polymerase Chain Reaction
        4. Electrophoresis
        5. Mass Spectrometry
      2. By Application
        1. Drug Discovery
        2. Neurology
        3. Oncology
        4. Pain Management
        5. Others
      3. By End User
        1. Hospitals
        2. Research organizations
        3. Others
      4. By Distribution Channel
        1. Hospital Pharmacy
        2. Online Pharmacy
        3.  Retail Pharmacy
      5. By Region
        1. North America
        2. Europe
        3. Asia Pacific
        4. Latin America
        5. Middle East and Africa
  5. North America Pharmacogenomics Market
      1. Market Size & Forecast, 2018–2028
      2. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Technology
      2. By Application
      3. By End User
      4. By Distribution Channel
      5. By Country
        1. United States
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        2. Canada
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
  6. Europe Pharmacogenomics Market
    1. Market Size & Forecast, 2018–2028
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Technology
      2. By Application
      3. By End User
      4. By Distribution Channel
      5. By Country
        1. Germany
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        2. United Kingdom
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        3. Italy
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        4. France
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        5. Spain
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        6. The Netherlands
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        7. Belgium
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        8. NORDIC Countries
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        9. Rest of Europe
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
  7. Asia Pacific Pharmacogenomics Market
    1. Market Size & Forecast, 2018–2028
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Technology
      2. By Application
      3. By End User
      4. By Distribution Channel
      5. By Country
        1. China
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        2. India
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        3. Japan
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        4. South Korea
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        5. Australia & New Zealand
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        6. Indonesia
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        7. Malaysia
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        8. Singapore
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        9. Philippines
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        10. Vietnam
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        11. Rest of Asia Pacific
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
  8. Latin America Pharmacogenomics Market
    1. Market Size & Forecast, 2018–2028
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Technology
      2. By Application
      3. By End User
      4. By Distribution Channel
      5. By Country
        1. Brazil
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        2. Mexico
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        3. Argentina
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        4. Peru
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        5. Colombia
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        6. Rest of Latin America
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
  9. Middle East & Africa Pharmacogenomics Market
    1. Market Size & Forecast, 2018–2028
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Technology
      2. By Application
      3. By End User
      4. By Distribution Channel
      5. By Country
        1. Saudi Arabia
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        2. UAE
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        3. Qatar
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        4. Kuwait
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        5. Iran
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        6. South Africa
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        7. Nigeria
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        8. Kenya
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        9. Egypt
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        10. Morocco
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        11. Algeria
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
        12. Rest of Middle East & Africa
          1. By Technology
          2. By Application
          3. By End User
          4. By Distribution Channel
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Pharmacogenomics Company Market Share Analysis, 2021
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, and others)
  11. Impact of Covid-19 on Global Pharmacogenomics Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Novartis AG
    2. Mylan N.V.
    3. Ferndale Pharma Group, Inc.
    4. F. Hoffmann-La Roche Ltd
    5. Pfizer Inc.
    6. Takeda Pharmaceutical Company Limited
    7. AstraZeneca
    8. GlaxoSmithKline plc
    9. Bristol-Myers Squibb Company
    10. Eli Lilly and Company
    11. Boehringer Ingelheim International GmbH
    12. AbbVie Inc
    13. Allergan
    14. Abbott
    15. Bayer AG
    16. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumptions & Limitations

 

*Financial information in case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

 

 

List of Figures

Figure 1        Global Pharmacogenomics Market Segmentation

Figure 2        Global Pharmacogenomics Market Value Chain Analysis

Figure 3        Company Market Share Analysis, 2021

Figure 4        Global Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 5        Global Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 6        Global Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 7        Global Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 8        Global Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 9        Global Pharmacogenomics Market Share, By Region, By Value, 2018–2028

Figure 10       North America Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 11       North America Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 12       North America Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 13       North America Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 14       North America Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 15       North America Pharmacogenomics Market Share, By Country, By Value, 2018–2028

Figure 16       United States Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 17       United States Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 18       United States Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 19       United States Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 20       United States Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 21       Canada Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 22       Canada Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 23       Canada Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 24       Canada Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 25       Canada Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 26       Europe Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 27       Europe Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 28       Europe Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 29       Europe Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 30       Europe Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 31       Europe Pharmacogenomics Market Share, By Country, By Value, 2018–2028

Figure 32       Germany Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 33       Germany Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 34       Germany Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 35       Germany Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 36       Germany Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 37       UK Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 38       UK Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 39       UK Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 40       UK Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 41       UK Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 42       Italy Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 43       Italy Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 44       Italy Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 45       Italy Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 46       Italy Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 47       France Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 48       France Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 49       France Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 50       France Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 51       France Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 52       Spain Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 53       Spain Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 54       Spain Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 55       Spain Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 56       Spain Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 57       The Netherlands Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 58       The Netherlands Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 59       The Netherlands Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 60       The Netherlands Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 61       The Netherlands Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 62       Belgium Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 63       Belgium Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 64       Belgium Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 65       Belgium Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 66       Belgium Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 67       NORDIC Countries Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 68       NORDIC Countries Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 69       NORDIC Countries Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 70       NORDIC Countries Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 71       NORDIC Countries Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 72       Rest of Europe Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 73       Rest of Europe Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 74       Rest of Europe Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 75       Rest of Europe Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 76       Rest of Europe Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 77       Asia-Pacific Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 78       Asia-Pacific Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 79       Asia-Pacific Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 80       Asia-Pacific Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 81       Asia-Pacific Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 82       Asia-Pacific Pharmacogenomics Market Share, By Country, By Value, 2018–2028

Figure 83       China Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 84       China Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 85       China Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 86       China Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 87       China Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 88       India Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 89       India Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 90       India Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 91       India Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 92       India Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 93       Japan Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 94       Japan Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 95       Japan Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 96       Japan Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 97       Japan Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 98       South Korea Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 99       South Korea Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 100     South Korea Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 101     South Korea Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 102     South Korea Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 103     Australia & New Zealand Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 104     Australia & New Zealand Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 105     Australia & New Zealand Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 106     Australia & New Zealand Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 107     Australia & New Zealand Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 108     Indonesia Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 109     Indonesia Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 110     Indonesia Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 111     Indonesia Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 112     Indonesia Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 113     Malaysia Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 114     Malaysia Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 115     Malaysia Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 116     Malaysia Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 117     Malaysia Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 118     Singapore Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 119     Singapore Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 120     Singapore Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 121     Singapore Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 122     Singapore Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 123     Philippines Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 124     Philippines Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 125     Philippines Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 126     Philippines Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 127     Philippines Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 128     Vietnam Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 129     Vietnam Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 130     Vietnam Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 131     Vietnam Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 132     Vietnam Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 133     Rest of APAC Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 134     Rest of APAC Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 135     Rest of APAC Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 136     Rest of APAC Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 137     Rest of APAC Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 138     Latin America Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 139     Latin America Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 140     Latin America Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 141     Latin America Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 142     Latin America Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 143     Latin America Pharmacogenomics Market Share, By Country, By Value, 2018–2028

Figure 144     Brazil Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 145     Brazil Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 146     Brazil Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 147     Brazil Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 148     Brazil Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 149     Mexico Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 150     Mexico Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 151     Mexico Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 152     Mexico Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 153     Mexico Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 154     Argentina Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 155     Argentina Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 156     Argentina Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 157     Argentina Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 158     Argentina Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 159     Peru Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 160     Peru Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 161     Peru Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 162     Peru Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 163     Peru Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 164     Colombia Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 165     Colombia Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 166     Colombia Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 167     Colombia Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 168     Colombia Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 169     Rest of LATAM Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 170     Rest of LATAM Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 171     Rest of LATAM Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 172     Rest of LATAM Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 173     Rest of LATAM Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 174     Middle East & Africa Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 175     Middle East & Africa Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 176     Middle East & Africa Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 177     Middle East & Africa Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 178     Middle East & Africa Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 179     Middle East & Africa Pharmacogenomics Market Share, By Country, By Value, 2018–2028

Figure 180     Saudi Arabia Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 181     Saudi Arabia Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 182     Saudi Arabia Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 183     Saudi Arabia Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 184     Saudi Arabia Pharmacogenomics Market Share, By Distriibution Channel, By Value, 2018–2028

Figure 185     UAE Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 186     UAE Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 187     UAE Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 188     UAE Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 189     UAE Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 190     Qatar Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 191     Qatar Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 192     Qatar Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 193     Qatar Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 194     Qatar Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 195     Kuwait Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 196     Kuwait Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 197     Kuwait Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 198     Kuwait Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 199     Kuwait Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 200     Iran Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 201     Iran Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 202     Iran Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 203     Iran Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 204     Iran Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 205     South Africa Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 206     South Africa Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 207     South Africa Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 208     South Africa Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 209     South Africa Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 210     Nigeria Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 211     Nigeria Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 212     Nigeria Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 213     Nigeria Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 214     Nigeria Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 215     Kenya Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 216     Kenya Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 217     Kenya Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 218     Kenya Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 219     Kenya Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 220     Egypt Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 221     Egypt Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 222     Egypt Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 223     Egypt Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 224     Egypt Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 225     Morocco Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 226     Morocco Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 227     Morocco Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 228     Morocco Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 229     Morocco Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 230     Algeria Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 231     Algeria Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 232     Algeria Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 233     Algeria Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 234     Algeria Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

Figure 235     Rest of Middle East & Africa Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Figure 236     Rest of Middle East & Africa Pharmacogenomics Market Share, By Technology, By Value, 2018–2028

Figure 237     Rest of Middle East & Africa Pharmacogenomics Market Share, By Application, By Value, 2018–2028

Figure 238     Rest of Middle East & Africa Pharmacogenomics Market Share, By End User, By Value, 2018–2028

Figure 239     Rest of Middle East & Africa Pharmacogenomics Market Share, By Distribution Channel, By Value, 2018–2028

         

List of Tables

Table 1         Global Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 2         Global Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 3         Global Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 4         Global Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 5         Global Pharmacogenomics Market Size, By Region, By Value, 2018–2028

Table 6         North America Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 7         North America Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 8         North America Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 9         North America Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 10        North America Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 11        North America Pharmacogenomics Market Size, By Country, By Value, 2018–2028

Table 12        United States Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 13        United States Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 14        United States Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 15        United States Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 16        United States Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 17        Canada Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 18        Canada Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 19        Canada Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 20        Canada Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 21        Canada Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 22        Europe Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 23        Europe Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 24        Europe Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 25        Europe Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 26        Europe Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 27        Europe Pharmacogenomics Market Size, By Country, By Value, 2018–2028

Table 28        Germany Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 29        Germany Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 30        Germany Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 31        Germany Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 32        Germany Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 33        UK Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 34        UK Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 35        UK Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 36        UK Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 37        UK Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 38        Italy Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 39        Italy Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 40        Italy Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 41        Italy Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 42        Italy Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 43        France Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 44        France Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 45        France Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 46        France Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 47        France Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 48        Spain Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 49        Spain Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 50        Spain Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 51        Spain Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 52        Spain Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 53        The Netherlands Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 54        The Netherlands Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 55        The Netherlands Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 56        The Netherlands Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 57        The Netherlands Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 58        Belgium Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 59        Belgium Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 60        Belgium Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 61        Belgium Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 62        Belgium Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 63        NORDIC Countries Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 64        NORDIC Countries Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 65        NORDIC Countries Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 66        NORDIC Countries Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 67        NORDIC Countries Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 68        Rest of Europe Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 69        Rest of Europe Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 70        Rest of Europe Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 71        Rest of Europe Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 72        Rest of Europe Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 73        Asia-Pacific Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 74        Asia-Pacific Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 75        Asia-Pacific Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 76        Asia-Pacific Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 77        Asia-Pacific Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 78        Asia-Pacific Pharmacogenomics Market Size, By Country, By Value, 2018–2028

Table 79        China Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 80        China Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 81        China Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 82        China Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 83        China Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 84        India Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 85        India Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 86        India Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 87        India Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 88        India Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 89        Japan Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 90        Japan Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 91        Japan Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 92        Japan Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 93        Japan Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 94        South Korea Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 95        South Korea Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 96        South Korea Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 97        South Korea Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 98        South Korea Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 99        Australia & New Zealand Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 100      Australia & New Zealand Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 101      Australia & New Zealand Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 102      Australia & New Zealand Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 103      Australia & New Zealand Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 104      Indonesia Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 105      Indonesia Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 106      Indonesia Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 107      Indonesia Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 108      Indonesia Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 109      Malaysia Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 110      Malaysia Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 111      Malaysia Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 112      Malaysia Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 113      Malaysia Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 114      Singapore Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 115      Singapore Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 116      Singapore Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 117      Singapore Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 118      Singapore Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 119      Philippines Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 120      Philippines Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 121      Philippines Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 122      Philippines Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 123      Philippines Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 124      Vietnam Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 125      Vietnam Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 126      Vietnam Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 127      Vietnam Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 128      Vietnam Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 129      Rest of APAC Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 130      Rest of APAC Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 131      Rest of APAC Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 132      Rest of APAC Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 133      Rest of APAC Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 134      Latin America Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 135      Latin America Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 136      Latin America Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 137      Latin America Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 138      Latin America Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 139      Latin America Pharmacogenomics Market Size, By Country, By Value, 2018–2028

Table 140      Brazil Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 141      Brazil Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 142      Brazil Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 143      Brazil Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 144      Brazil Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 145      Mexico Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 146      Mexico Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 147      Mexico Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 148      Mexico Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 149      Mexico Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 150      Argentina Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 151      Argentina Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 152      Argentina Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 153      Argentina Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 154      Argentina Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 155      Peru Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 156      Peru Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 157      Peru Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 158      Peru Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 159      Peru Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 160      Colombia Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 161      Colombia Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 162      Colombia Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 163      Colombia Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 164      Colombia Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 165      Rest of LATAM Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 166      Rest of LATAM Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 167      Rest of LATAM Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 168      Rest of LATAM Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 169      Rest of LATAM Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 170      Middle East & Africa Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 171      Middle East & Africa Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 172      Middle East & Africa Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 173      Middle East & Africa Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 174      Middle East & Africa Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 175      Middle East & Africa Pharmacogenomics Market Size, By Country, By Value, 2018–2028

Table 176      Saudi Arabia Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 177      Saudi Arabia Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 178      Saudi Arabia Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 179      Saudi Arabia Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 180      Saudi Arabia Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 181      UAE Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 182      UAE Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 183      UAE Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 184      UAE Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 185      UAE Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 186      Qatar Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 187      Qatar Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 188      Qatar Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 189      Qatar Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 190      Qatar Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 191      Kuwait Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 192      Kuwait Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 193      Kuwait Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 194      Kuwait Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 195      Kuwait Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 196      Iran Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 197      Iran Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 198      Iran Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 199      Iran Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 200      Iran Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 201      South Africa Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 202      South Africa Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 203      South Africa Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 204      South Africa Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 205      South Africa Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 206      Nigeria Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 207      Nigeria Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 208      Nigeria Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 209      Nigeria Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 210      Nigeria Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 211      Kenya Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 212      Kenya Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 213      Kenya Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 214      Kenya Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 215      Kenya Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 216      Egypt Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 217      Egypt Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 218      Egypt Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 219      Egypt Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 220      Egypt Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 221      Morocco Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 222      Morocco Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 223      Morocco Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 224      Morocco Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 225      Morocco Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 226      Algeria Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 227      Algeria Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 228      Algeria Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 229      Algeria Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 230      Algeria Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 231      Rest of Middle East & Africa Pharmacogenomics Market Size, By Value (USD Million), 2018–2028

Table 232      Rest of Middle East & Africa Pharmacogenomics Market Size, By Technology, By Value, 2018–2028

Table 233      Rest of Middle East & Africa Pharmacogenomics Market Size, By Application, By Value, 2018–2028

Table 234      Rest of Middle East & Africa Pharmacogenomics Market Size, By End User, By Value, 2018–2028

Table 235      Rest of Middle East & Africa Pharmacogenomics Market Size, By Distribution Channel, By Value, 2018–2028

Table 236      Novartis AG Company Overview

Table 237      Novartis AG Financial Overview

Table 238      Mylan N.V. Company Overview

Table 239      Mylan N.V. Financial Overview

Table 240      Ferndale Pharma Group, Inc. Company Overview

Table 241      Ferndale Pharma Group, Inc. Financial Overview

Table 242      F. Hoffmann-La Roche Ltd Company Overview

Table 243      F. Hoffmann-La Roche Ltd Financial Overview

Table 244      Pfizer Inc. Company Overview

Table 245      Pfizer Inc. Financial Overview

Table 246      Takeda Pharmaceutical Company Limited Company Overview

Table 247      Takeda Pharmaceutical Company Limited Financial Overview

Table 248      AstraZeneca Company Overview

Table 249      AstraZeneca Financial Overview

Table 250      GlaxoSmithKline plc Company Overview

Table 251      GlaxoSmithKline plc Financial Overview

Table 252      Bristol-Myers Squibb Company Overview

Table 253      Bristol-Myers Squibb Company Financial Overview

Table 254      Eli Lilly and Company Overview

Table 255      Eli Lilly and Company Financial Overview

Table 256      Boehringer Ingelheim International GmbH Company Overview

Table 257      Boehringer Ingelheim International GmbH Financial Overview

Table 258      AbbVie Inc Company Overview

Table 259      AbbVie Inc Financial Overview

Table 260      Allergan Company Overview

Table 261      Allergan Financial Overview

Table 262      Abbott Company Overview

Table 263      Abbott Financial Overview

Table 264      Bayer AG Company Overview

Table 265      Bayer AG Financial Overview

 

 

 

Market Segmentation

By Technology

  • DNA Sequencing

  • Microarray

  • Polymerase Chain Reaction

  • Electrophoresis

  • Mass Spectrometry

By Application

  • Drug Discovery

  • Neurology

  • Oncology

  • Pain Management

  • Others

By End User

  • Hospitals

  • Research organizations

  • Others

By Distribution Channel

  • Hospital Pharmacy

  • Online Pharmacy

  • Retail Pharmacy

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: The hospital segment holds the highest market share in Global Pharmacogenomics Market.
Ans: During the forecast period between 2022 and 2028, the size of Global Pharmacogenomics Market is projected to grow at a CAGR of 12.4%.
Ans: Major factors driving the growth of Global Pharmacogenomics Market include an increase in the prevalence of chronic diseases, a rise in the demand for precision medicine, an increase in the use of Sanger technology and next-generation sequencing in academic and institutional research projects, an increase in government funding for healthcare infrastructure, and an increase in the strategic partnerships between market players.
Ans: Key players in Global Pharmacogenomics Market include Novartis AG, Mylan N.V., Ferndale Pharma Group, Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, AstraZeneca, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Eli Lilly and Company, Boehringer Ingelheim International GmbH, AbbVie Inc, Allergan, Abbott, and Bayer AG.
Ans: The polymerase chain reaction segment accounted for the highest share of Global Pharmacogenomics Market.